Back to Authors

Shing, Vivian

Mayo Clinic

Mayo Clinic

Citations 2

Pleuroparenchymal fibroelastosis from a rheumatologic perspective
Diaz‐Menindez, Maximiliano , VERGARA, ALEJANDRO DIAZ ARUMIR, Shing, Vivian, Harvey, Carolyn Mead, Martinez, Ana C. Zamora, Nagaraja, Vivek, Diaz Arumir Vergara, Alejandro, Mead Harvey, Carolyn, Zamora Martinez, Ana C, Harvey, Carolyn Mead, Zamora, Ana, Nagaraja, Vivek

Therapeutic Advances in Respiratory Disease | May 6, 2026 | Volume: 20 | Issue: No issue available | Pages: No page available

10.1177/17534666261445202 Get It

Background: Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial lung disease (ILD) associated with systemic autoimmune rheumatic diseases (SARDs). Its clinical characteristics and outcomes in SARDs remain poorly defined. Objectives: To describe demographics, imaging patterns, and outcomes in SARD-associated PPFE. Methods: Patients diagnosed with PPFE and SARDs at Mayo Clinic (2000-2024) were included. PPFE diagnosis was confirmed by high-resolution computed tomography, and SARD diagnoses were established by rheumatologists. Results: Fifteen of 62 patients with PPFE had SARDs with majority having systemic sclerosis (SSc)(n= 7, 46%). Median age at PPFE diagnosis was 57.2 years; 80% were female; 40% were ever-smokers; 40% required supplemental oxygen; 5 had pulmonary hypertension. Coexisting ILD patterns included UIP (26.7%) and NSIP (20%). Coexisting ILD patterns included usual interstitial pneumonia (26.7%) and nonspecific interstitial pneumonia (20%). Three patients died, including two with SSc. Conclusion: Systemic sclerosis was the most frequently observed SARD among patients with PPFE, and may coexist with other ILD patterns; recognition may inform risk stratification, multidisciplinary evaluation, and longitudinal follow-up.
Benefits and risks of hair, skin, and nail supplements in older adults
Shing, Vivian, Sierra, Ana Aragon, Shing, Vivian, Shah, Amit

International Journal of Women’s Dermatology | November 26, 2025 | Volume: 11 | Issue: 4 | Pages: e236

10.1097/jw9.0000000000000236 Get It

Many older adults, particularly older women, use over-the-counter supplements for antiaging benefits, including for hair and skin. The supplement industry is unregulated by the Food and Drug Administration, and the interactions between supplements and medications are often overlooked by both patients and physicians. This article discusses the proposed mechanism of action, common misconceptions, possible benefits, and potential side effects of the most commonly used antiaging skin supplements by women, including biotin, nicotinamide, hyaluronic acid, collagen, zinc, vitamin C, vitamin A, vitamin E, and other antioxidants. Supplements may also interfere with common blood tests, such as biotin with the thyroid and troponin cardiac enzyme tests, which patients and their clinicians must be aware of and account for when interpreting lab results. Other supplements, such as zinc, are commonly taken in excess and may result in deficiencies in the absorption of other minerals, such as copper. Over-supplementation of fat-soluble vitamins, such as vitamin A and vitamin E, can result in toxic levels since excess is not excreted in the urine. The clinician caring for older patients’ skin and nails must ask older patients about supplement use and be aware of the potential harms of these supplements in some patients.